Eli Lilly Will Use GeneNews' Osteoarthritis Biomarker Technology

The pharmaceutical firm will have access to GeneNews' genomic biomarker program.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.